Company
3D Global Biotech, Inc.
Headquarters: New Taipei City, Taiwan
Employees: 26
Market Cap
TW$1.12 Billion
TWD as of Jan. 1, 2024
US$36.6 Million
3D Global Biotech, Inc. Categories
Taiwan Healthcare BiotechnologyTaiwan Healthcare Taiwan Biotechnology
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $461.52 B |
| Vertex Pharmaceuticals Incorporated | $107.23 B |
| Regeneron Pharmaceuticals, Inc. | $100.01 B |
| CSL Limited | $94.74 B |
| Marinomed Biotech AG | $73.23 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
3D Global Biotech Inc. develops a 3D human organ bio-printing technology platform and composite bio-ink for printing a variety of cells to reconstruct tissues and organs. The company offers reconstruction of human tissues and organs; and manufactures customized and personalized medical devices. It provides 3D printing technology and inspection services. The company offers artificial bone grafting products, cranial and maxillofacial implants, bio-dressings, bio-inks, and 3D printing equipment, as well as orthodontic, PacDent, and ophthalmic products. It serves medical centers, research institutions, and companies and distributors to establish an interdisciplinary alliance encompassing industry, government, academia, research, and medicine. The company was founded in 2014 and is based in New Taipei City, China.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
3D Global Biotech, Inc. has the following listings and related stock indices.
Stock: TWSE: 6808 wb_incandescent